Cytokinetics Inc. buy Truist Financial Co.
Start price
03.02.26
/
50%
€56.50
Target price
03.02.27
€77.92
Performance (%)
19.04%
Price
09:30
€67.26
Summary
This prediction is currently active. The prediction currently has a performance of 19.04%. This prediction currently runs until 03.02.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -0.778% | -0.778% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Truist Financial Corporation from $84.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.00
29.05.24
29.05.24
€64.57
29.05.25
29.05.25
-40.00%
30.05.25
30.05.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
08.04.24
08.04.24
€79.21
08.04.25
08.04.25
-53.24%
09.04.25
09.04.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
28.12.23
28.12.23
€77.64
28.12.24
28.12.24
-41.05%
29.12.24
29.12.24